 "Cipla, Cipla logo, Cipla headquarters")
The stock of pharma major Cipla was the biggest gainer in the Nifty Pharma and Healthcare indices, jumping about 5.5 per cent in trade on Tuesday. The Healthcare index also saw the largest increase among sectoral indices with a rise of about 3 per cent.
The Street is betting on a strong launch pipeline in the US, market share gains of recent launches and rising scale in the consumer business as some of the positives for the third-largest listed pharma entity.
The company has captured a 9.3 per cent market share as of August in Lanreotide, a drug used in
